Physiological Effect | Genetic Alterations | |||
---|---|---|---|---|
α2A-D79N | α2A-KO | α2B-KO | α2C-KO | |
Hypotensive effects of α2-adrenergic receptor agonist | X | X | ↑ | − |
Bradycardic effects of α2-adrenergic receptor agonist | ↓ | ↓ | − | − |
Hypertensive effects of α2-adrenergic receptor agonist | ↓1-a | − | X | − |
Cardiovascular effects of imidazoline agonist | X | |||
Resting heart rate | − | ↑ | − | − |
Resting blood pressure | − | − | − | − |
Salt-induced hypertension | X1-b | − | ||
Sedative effects of dexmedetomidine | X | − | − | |
Antinociceptive effects of α2-adrenergic receptor agonist | X/↓1-c | − | − | |
Antinociceptive effects of moxonidine | ↓ | |||
Adrenergic-opioid synergy in spinal antinociception | X | |||
Anesthetic-sparing effects of dexmedetomidine | X | |||
Hypothermic effects of dexmedetomidine | X | − | −/↓ | |
Antiepileptogenic effects of endogenous norepinephrine | X | |||
Presynaptic inhibition of norepinephrine release | − | ↓ | − | ↓1-d |
Autoinhibition of locus coeruleus | X |
The α2A-subtype mediates most of the classical effects of α2-adrenergic receptor agonists.